• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » AstraZeneca donates Brixham Environmental Laboratory to Plymouth University

AstraZeneca donates Brixham Environmental Laboratory to Plymouth University

December 9, 2013
CenterWatch Staff

AstraZeneca will donate its Environmental Laboratory in Brixham to Plymouth University to ensure the lab continues to serve scientific and research purposes.

Plymouth University plans to use the site to create a global research and education facility. The -university, known for its marine and environmental science experience, also plans to offer commercial innovation opportunities through the facility via the region’s Growth Acceleration and Investment Network (GAIN).

Steve Rumford, head of the environment team at AstraZeneca, said, “We made the decision in October to close our Brixham site as operating an environmental research laboratory is not a core part of AstraZeneca’s strategy. However, our aim has been to ensure the laboratory and its state-of-the-art facilities remain in use for scientific purposes.”

Professor Wendy Purcell, Plymouth University vice chancellor, said, “We have undertaken a number of research projects with AstraZeneca over the years, and we’re very familiar with the specialist facilities available at the Brixham Environmental Laboratory. We are determined to leverage our academic credentials and enterprise mission to further develop the site into an international center of excellence for marine and environmental research. Through this, we hope to support the creation of highly-skilled jobs that underpin sustainable growth in the region.”

The agreement does not include the transfer of AstraZeneca staff or third-party work commitments. AstraZeneca plans to transfer ownership of the lab to the university by the end of April 2014.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing